Rajini Kolure

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Development and Validation of a Rp-Hplc Method for the Quantification of Favipiravir and its Impurities in Pharmaceutical Dosage Forms
  Biosciences Biotechnology Research Asia 2025 DOI: 10.13005/bbra/3469
  +Save
• Immunotherapeutics in Clinical Trials for Cervical Cancer
  2025
  +Save
• Monoclonal Antibodies in Clinical Trials for Breast Cancer Treatment
  Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2025 DOI: 10.1089/mab.2024.0018
  +Save
• Data Analytics for Pharmacovigilance and Drug Safety
  Recent Developments in Microbiology, Biotechnology and Pharmaceutical Sciences 2025 DOI: 10.1201/9781003618140-136
  +Save
• Design and Optimization of Microfluidic Devices for Drug Screening Applications
  Recent Developments in Microbiology, Biotechnology and Pharmaceutical Sciences 2025 DOI: 10.1201/9781003618140-115
  +Save
• Evaluation of the Relationship between Ocular Damage and Monocular Blindness Related to Ophthalmic Illness
  Recent Developments in Microbiology, Biotechnology and Pharmaceutical Sciences 2025 DOI: 10.1201/9781003618140-163
  +Save
• Anticlastogenic activity of ethanolic extract of Lagenaria siceraria fruit (ELSF) against cyclophosphamide induced genotoxicity in mice
  Discover Applied Sciences 2024 DOI: 10.1007/s42452-024-06042-6
  +Save
• Protective effect of Enicostemma axillare - Swertiamarin on oxidative stress against nicotine-induced liver damage in SD rats,Effet protecteur de l'Enicostemma axillare - Swertiamarine sur le stress oxydatif contre les lésions foie induites par la nicoti…
  Annales Pharmaceutiques Francaises 2024 DOI: 10.1016/j.pharma.2024.03.009
  +Save
• Hepatoprotective effect of Swertiamarin from Cytarabine Induced Hepatotoxicity in Pregnant rats
  Research Journal of Pharmacy and Technology 2023 DOI: 10.52711/0974-360X.2023.00923
  +Save
• Liquid Chromatographic Approach for Analysis of Favipiravir–A Repurpose Drug for COVID-19
  International Journal of Pharmaceutical Quality Assurance 2023 DOI: 10.25258/ijpqa.14.1.04
  +Save